drugset / Trial / NCT02280317
Dose Finding Safety Study of VAL201 in Cancer Patients
Non-randomizedSequentialOpen-labelTreatment
Summary
Dose finding safety study of VAL201 in cancer patients.
Timeline
- Start
- 2014-10
- Primary completion
- 2020-01-27
- Completion
- 2020-01-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VAL201 | Unknown | 0.5 mg/kg | Subcutaneous |
| Subject | VAL201 | Unknown | 1 mg/kg | Subcutaneous |
| Subject | VAL201 | Unknown | 2 mg/kg | Subcutaneous |
| Subject | VAL201 | Unknown | 4 mg/kg | Subcutaneous |
| Subject | VAL201 | Unknown | 8 mg/kg | Subcutaneous |